Page last updated: 2024-10-26

edrophonium and Auricular Flutter

edrophonium has been researched along with Auricular Flutter in 4 studies

Edrophonium: A rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis. It has also been used as an antidote to curare principles.
edrophonium : A quaternary ammonium ion that is N-ethyl-N,N-dimethylanilinium in which one of the meta positions is substituted by a hydroxy group. It is a reversible inhibitor of cholinesterase, with a rapid onset (30-60 seconds after injection) but a short duration of action (5-15 minutes). The chloride salt is used in myasthenia gravis both diagnostically and to distinguish between under- or over-treatment with other anticholinesterases. It has also been used for the reversal of neuromuscular blockade in anaesthesia, and for the management of poisoning due to tetrodotoxin, a neuromuscular blocking toxin found in puffer fish and other marine animals.

Research Excerpts

ExcerptRelevanceReference
"Atrial flutter has a fully excitable gap, and procainamide does not convert the gap from full to partial excitability."1.29Pharmacologic alterations in human type I atrial flutter cycle length and monophasic action potential duration. Evidence of a fully excitable gap in the reentrant circuit. ( Ellenbogen, KA; Stambler, BS; Wood, MA, 1996)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stambler, BS2
Wood, MA1
Ellenbogen, KA2
Cummings, P1
Reddy, RC1
Gould, L1
Gomprecht, RF1

Other Studies

4 other studies available for edrophonium and Auricular Flutter

ArticleYear
Pharmacologic alterations in human type I atrial flutter cycle length and monophasic action potential duration. Evidence of a fully excitable gap in the reentrant circuit.
    Journal of the American College of Cardiology, 1996, Volume: 27, Issue:2

    Topics: Action Potentials; Adenosine; Aged; Anti-Arrhythmia Agents; Atrial Flutter; Cardiac Pacing, Artifici

1996
Elucidating the mechanisms of atrial flutter cycle length variability using power spectral analysis techniques.
    Circulation, 1996, Nov-15, Volume: 94, Issue:10

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Atrial Flutter; Edrophonium; Heart; Heart Transplantation;

1996
Supraventricular tachycardias in the emergency room.
    Comprehensive therapy, 1985, Volume: 11, Issue:2

    Topics: Atrial Fibrillation; Atrial Flutter; Digoxin; Edrophonium; Electric Countershock; Emergencies; Human

1985
Use of edrophonium (tensilon) in the evaluation of cardiac arrhythmias.
    American heart journal, 1971, Volume: 82, Issue:6

    Topics: Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Diagnosis, Differentia

1971